[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Publications found: 1,364
Sort by:
Global Dermatology Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...

April 2020 350 pages
Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025 US$ 5,650.00

... following pointers: Market Penetration: Comprehensive information on the product portfolios of top players in the digital therapeutics market. The report analyzes the digital therapeutics market by application, sales channel, and region Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the digital therapeutics market ...

March 2020 166 pages
Digital Therapeutics: A New Age Medicine US$ 2,500.00

REPORT SCOPE: The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanc...

March 2020 13 pages
Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

This report can be delivered to the clients within 48 Business Hours The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, ac...

March 2020 100 pages
Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type, By Region, And Segment Forecasts, 2020 - 2027 US$ 5,950.00

The global gene therapy market size is expected to reach USD 39.54 million by 2026. Rising competition among manufacturers ... better efficacy as compared to gene therapy alone. Cancer held the dominant share in the market in 2017 owing to relatively high adoption of gene therapies for cancer treatment. Continual ...

February 2020 160 pages
Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report By Therapy Type (Cell, CAR-T, Gene Therapy, Stem Cell, Non-stem Cell), By Region, And Segment Forecasts, 2020 - 2026 US$ 5,950.00

The global advanced therapy medicinal products market size is expected to reach USD 9.6 billion by 2026, expanding at a CAGR of 17.4% over the forecast period, according to a new report published by G...

February 2020 140 pages
Dermatologicals in South Africa US$ 990.00

... associated with a lack of hygiene or a... Euromonitor International's Dermatologicals in South Africa report offers a comprehensive guide to the size and shape ... Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical ...

February 2020 22 pages
Amyloidosis Global Clinical Trials Review, H1, 2020 US$ 2,500.00

... clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial ...

January 2020 221 pages
Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral)), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region - Global Forecast to 2024 US$ 5,650.00

“High incidence of cancer & other target diseases is a major factor driving the growth of the gene therapy market” The global gene therapy market is projected to reach USD 13.0 billion by 2024 from US...

January 2020 136 pages
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026 US$ 3,000.00

... Peptide Therapeutics, Peptide Vaccine & Peptide Hormone Global Peptide Therapeutics Market Dynamics Global Peptide Clinical Pipeline by Company, Indication & Phase Global Peptide Pipeline: 722 Peptides Majority Peptides in Preclinical Phase: 308 Peptides Commercially Available Peptides: 136 Peptides ...

January 2020 1500 pages
Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026 US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026' Report Highlight:...

January 2020 1500 pages
HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal US$ 6,995.00

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal SUMMARY Human immunodeficiency virus (HIV) is a chronic disease that can be transmitted through...

December 2019 63 pages
Proton Therapy in Cancer: Global Markets US$ 5,500.00

REPORT SCOPE: BCC Research’s new report, “Proton Therapy in Cancer: Global Markets,” provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and...

December 2019 185 pages
Highs and Lows of Stem Cell Therapies: Off- The-Shelf Solutions US$ 3,950.00

REPORT INCLUDES: An overview of recent advances in stem cell therapies and coverage of potential stem cells used for regenerative advanced therapiesDiscussion on role of genomic and epigenomics manip...

December 2019 25 pages
Global CAR T Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026 US$ 3,950.00

Value Market Research’s latest report on the Global CAR T Cell Therapy Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the...

December 2019 100 pages
Cystic Fibrosis (CF) Therapeutics Market by Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, and CFTR Modulators) and Route of Administration (Oral and Inhaled): Global Opportunity Analysis and Industry Forecast, 2019-2026 US$ 5,370.00

The global cystic fibrosis therapeutics market was valued at $4,615.4 million in 2018 and is expected to reach $9,277.3 million by 2026, registering a CAGR of 9.2% from 2019 to 2026. Cystic fibrosis i...

November 2019 187 pages
Dermatologicals in Hong Kong, China US$ 990.00

... The humidity and high levels of air pollution seen in Hong Kong have been associated with skin problems, including inflammatory or allergic ... to have a negative impact on skin health. Euromonitor International's Dermatologicals in Hong Kong, China report offers a comprehensive guide to the size and shape of the ...

November 2019 21 pages
Allergic Rhinitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 166 pages
Urinary Incontinence - Pipeline Review, H2 2019 US$ 2,000.00

... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...

November 2019 72 pages
Endometriosis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 134 pages
Bronchitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 129 pages
Cystic Fibrosis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 489 pages
Polycystic Ovarian Syndrome - Pipeline Review, H2 2019 US$ 2,000.00

... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 50 pages
Sinusitis - Pipeline Review, H2 2019 US$ 2,000.00

... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 117 pages
Anal Cancer - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 475 pages
Choroidal Neovascularization - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 57 pages
Pulmonary Arterial Hypertension - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 364 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2019 US$ 2,000.00

... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 88 pages
Acromegaly - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 102 pages
Alopecia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 184 pages
Anthrax - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 110 pages
Cough - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 99 pages
Glomerulonephritis - Pipeline Review, H2 2019 US$ 2,000.00

... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 281 pages
Neutropenia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 131 pages
Ocular Hypertension - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 144 pages
Fragile X Syndrome - Pipeline Review, H2 2019 US$ 2,000.00

... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 172 pages
Hyperuricemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Hyperuricemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperuricemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 85 pages
Tinnitus - Pipeline Review, H2 2019 US$ 2,000.00

... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 48 pages
Bacterial Conjunctivitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 31 pages
Myocardial Infarction - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 332 pages
Myocardial Ischemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 87 pages
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2019 US$ 2,000.00

... (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

November 2019 280 pages
Rectal Cancer - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 186 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 137 pages
Dementia - Pipeline Review, H2 2019 US$ 2,000.00

... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 371 pages
Insulin Resistance - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 48 pages
Thalassemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 207 pages
Leiomyosarcoma - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 528 pages

Filters

Search

Publishers

1
403
1
1
1
98
2
5
3
10
2
5
1
6
7
2
1
1
2
70
21
3
2
21
1
4
1
2
2
6
10
8
1
58
9
2
1
3
1
1
4
21
3
2
3
1
15
18
5
1
2
16
8
1
2
1
5
1
19
20
19
27
19
5
324
17
12
2
4
1
7

Regions

1
4
2
1
7
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
1
5
4
2
2
2
1
1
1
1
1
1
1
2
1
1
1
2
2
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
2
10
30
13
1
5
4
2
2
2
2
3
2
4
22
2
15
2
5
14
12
4
33
1,084

Price

Date

Pages

Offers

98
4
1